Davenport & CO LLC Tempest Therapeutics, Inc. Transaction History
Davenport & CO LLC
- $16 Billion
- Q2 2024
A detailed history of Davenport & CO LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 50,000 shares of TPST stock, worth $72,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$72,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TPST
# of Institutions
28Shares Held
1.72MCall Options Held
30KPut Options Held
80.5K-
Black Rock Inc. New York, NY550KShares$797,8490.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$255,4790.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$223,6490.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$187,8890.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$153,1200.09% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $15.1M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...